Briefs: Venus Remedies and Shivalik Rasayan
Shivalik Rasayan Limited have successfully submitted USMDF for API " Palbociclib " to USFDA
Shivalik Rasayan Limited have successfully submitted USMDF for API " Palbociclib " to USFDA
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
The company has secured two orders for male condoms from CMSS worth Rs. 9.65 crores and Rs. 6.58 crores respectively
This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
Medway setup a state-of-the-art Heart Institute in Chennai
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
MedTech Mitra is a platform that will help the young talents of the country by holding their hands and giving them final shape to their research, knowledge and logic
This PAI-cum-GMP USFDA inspection was conducted from December 14 to December 22, 2023
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
Subscribe To Our Newsletter & Stay Updated